| PUBCHEM ID |
76960122
|
| UNII |
11M65MNP30
|
| Preferred Term |
N-((2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL) CEFPROZIL, (Z)-
|
| CAS |
|
| INCHIKEY |
SOVLMWIAFBYACS-CLDBKDIFSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
C/C=C\C(CS[C@H]1[C@H]2NC([C@H](c(cc3)ccc3O)NC([C@H](c(cc3)ccc3O)N)=O)=O)=C(C(O)=O)N1C2=O
|
| Total Surface Area |
380,74
|
| Relative PSA |
0,39578
|
| TPSA |
207,59
|
| cLogS |
-2,264
|
| MW |
538,579
|
| cLogP |
-1,6806
|
| H-Acceptors |
11
|
| H-Donors |
6
|
| Ro5 violations |
3
|
| Druglikeness |
7,6594
|
| DrugScore |
0,671463859233589
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA-
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,3434
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,28
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,4173
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
IV
|
| Rat Acute Toxicity |
1,605
|
| Carcinogenicity (Three-class) |
Non-required
|
